Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
108.97
-2.51 (-2.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
64
65
Next >
BioNTech Whale Trades For June 10
June 10, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 10 strange trades.
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Thursday, June 9
June 09, 2022
Reuters Blackstone Closes In Crown Bid After Australia Approvals: Reuters
Via
Benzinga
US Schedules Covid-19 Vaccines For Children Below Five Years
June 09, 2022
Via
Benzinga
HC Wainwright Says Non-mRNA COVID-19 Option Underappreciated
June 08, 2022
HC Wainwright says safety concerns were noted for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, but the strength of data showed that benefit outweighs risks.
Via
Benzinga
What's Next For Novavax Stock As COVID Vaccine Clears Key Hurdle In US
June 08, 2022
After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief.
Via
Benzinga
Short Volatility Alert: BioNTech SE
June 06, 2022
On Friday, shares of BioNTech SE (NASDAQ: BNTX) experienced volatile short activity. After the activity, the stock price went down -0.42% to $157.70. The overall sentiment...
Via
Benzinga
COVID-19 Vaccine Patent Waiver Expected Soon, Says WTO Head: Reuters
June 08, 2022
Via
Benzinga
Pfizer To Boost Production Of Oral COVID-19 Pill With $120M Michigan Investment
June 07, 2022
Pfizer, Inc. (NYSE: PFE) is upping its commitment to manufacture its oral COVID-19 pill Paxlovid in the United States.
Via
Benzinga
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
June 06, 2022
Via
Benzinga
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
June 03, 2022
These biotech stocks face some key make-or-break events in June that could have big implication for their futures.
Via
InvestorPlace
Morning Brief: Top Financial Stories Dominating on Thursday, June 2
June 02, 2022
Reuters
Via
Benzinga
Why The FDA Isn't The Battleground For Pfizer's, Moderna's Pediatric Covid Shots
June 02, 2022
FDA's OK is just step one. Then Pfizer and Moderna need to get parents on board.
Via
Investor's Business Daily
Pfizer Seeks FDA Approval For Three Covid Vaccine Doses For Children Below Five
June 02, 2022
Via
Benzinga
Jim Cramer Shares His Opinion On Roblox, Century Aluminum And More
June 01, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Roblox Corp (NASDAQ: RBLX) as it is not making money.
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
May 31, 2022
May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,...
Via
Benzinga
CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
May 26, 2022
Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited...
Via
Benzinga
7 of the Best Cheap Stocks to Buy for the Second Half of 2022
May 25, 2022
These are the best cheap stocks to invest in now. They all offer compelling buying opportunities in today's volatile market.
Via
InvestorPlace
Pfizer, BioNTech Say Three-Dose Covid Vaccine Is 80% Effective In Children Under 5
May 23, 2022
Pfizer tested a three-dose vaccine in nearly 1,700 children.
Via
Investor's Business Daily
Morning Brief: Top Financial Stories Dominating on Monday, May 23
May 23, 2022
CNBC US Announces Asia Economic Deal To Strengthen Foothold, Check China
Via
Benzinga
European Regulator Approves AstraZeneca's COVID-19 shot As Booster
May 23, 2022
Via
Benzinga
Pfizer-BioNTech's Third COVID-19 Vaccine Shot Shows 80% Efficacy In Youngest Children
May 23, 2022
Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine
Via
Benzinga
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
May 23, 2022
From
Pfizer Inc.
Via
Business Wire
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
May 22, 2022
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, May 20
May 20, 2022
Reuters
Via
Benzinga
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
CDC Recommends Pfizer/BioNTech COVID-19 Booster Shots For Kids Aged 5-11 Years
May 20, 2022
Via
Benzinga
Cramer Shares His Thoughts On BioNTech, Vertex Energy And More
May 19, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Veru Inc. (NASDAQ: VERU) is "up a great deal … we caught it much lower."
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
May 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
FDA Gives Green Signal To Pfizer/BioNTech's COVID-19 Booster For Kids 5-11 Years
May 17, 2022
Via
Benzinga
Pfizer Retakes A Key Line — And Drags BioNTech, Moderna With It
May 17, 2022
The FDA decision also prodded BioNTech and Moderna stocks higher.
Via
Investor's Business Daily
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
64
65
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.